Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-2-15
pubmed:abstractText
It is well known that treatment with aspirin plus heparin is effective for patients with antiphospholipid syndrome (APS) to prevent pregnancy loss. However, it is unclear if occasional antiphospholipid antibodies (aPL) are a risk factor and whether patients with aPL at one time point but not diagnosed as APS should be treated.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1046-7408
pubmed:author
pubmed:issnType
Print
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
235-41
pubmed:meshHeading
pubmed-meshheading:18275516-Abortion, Habitual, pubmed-meshheading:18275516-Adult, pubmed-meshheading:18275516-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:18275516-Antibodies, Anticardiolipin, pubmed-meshheading:18275516-Antibodies, Antiphospholipid, pubmed-meshheading:18275516-Anticoagulants, pubmed-meshheading:18275516-Aspirin, pubmed-meshheading:18275516-Cohort Studies, pubmed-meshheading:18275516-Female, pubmed-meshheading:18275516-Humans, pubmed-meshheading:18275516-Lupus Coagulation Inhibitor, pubmed-meshheading:18275516-Pregnancy, pubmed-meshheading:18275516-Pregnancy, High-Risk, pubmed-meshheading:18275516-Pregnancy Outcome, pubmed-meshheading:18275516-Pregnancy Rate, pubmed-meshheading:18275516-Retrospective Studies, pubmed-meshheading:18275516-Risk Factors, pubmed-meshheading:18275516-beta 2-Glycoprotein I
pubmed:year
2008
pubmed:articleTitle
Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.
pubmed:affiliation
Department of Obstetrics and Gynecology, Nagoya City University Medical School, Mizuho-ku, Nagoya, Aichi, Japan. og.mym@med.nagoya-cu.ac.jp
pubmed:publicationType
Journal Article